IA-2 modulates dopamine secretion in PC12 cells

Molecular and Cellular Endocrinology

Volumn 315, Issue 1-2, 2010, Pages 81-86

  Nishimura, Takuya ^a   Harashima, Shin ichi ^a,b   Yafang, Hu ^a,c   Notkins, Abner Louis ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Dopamine; Hormones; IA 2; Neurotransmitters; PC12; siRNA

Indexed keywords

DOPAMINE; INSULIN; MEMBRANE PROTEIN; NEUROTRANSMITTER; PHOGRIN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE LIKE PROTEIN 1A2; RAB PROTEIN; SECRETOGRANIN II; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DOPAMINE RELEASE; GENE OVEREXPRESSION; HORMONE RELEASE; INSULIN RELEASE; NEUROSECRETORY CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; AUTOANTIBODIES; CARCINOGENS; DOPAMINE; HUMANS; PC12 CELLS; POTASSIUM; RATS; RNA, SMALL INTERFERING; SECRETORY VESICLES; TETRADECANOYLPHORBOL ACETATE;

EID: 71849090237     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.09.023     Document Type: Article

References (27)

1. Cai T., Hirai H., Fukushige T., Yu P., Zhang G., Notkins A.L., and Krause M. Loss of the transcriptional repressor PAG-3/Gfi-1 results in enhanced neurosecretion that is dependent on the dense-core vesicle membrane protein IDA-1/IA-2. PLoS Genet. 5 (2009) e1000447
2. Gross S., Blanchetot C., Schepens J., Albet S., Lammers R., den Hertog J., and Hendriks W. Multimerization of the protein-tyrosine phosphatase (PTP)-like insulin-dependent diabetes mellitus autoantigens IA-2 and IA-2beta with receptor PTPs (RPTPs). Inhibition of RPTPalpha enzymatic activity. J. Biol. Chem. 277 (2002) 48139-48145
3. Harashima S., Clark A., Christie M.R., and Notkins A.L. The dense core transmembrane vesicle protein IA-2 is a regulator of vesicle number and insulin secretion. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 8704-8709
4. Henquin J.C., Nenquin M., Szollosi A., Kubosaki A., and Louis Notkins A. Insulin secretion in islets from mice with a double knockout for the dense core vesicle proteins islet antigen-2 (IA-2) and IA-2beta. J. Endocrinol. 196 (2008) 573-581
5. Hu Y.F., Zhang H.L., Cai T., Harashima S., and Notkins A.L. The IA-2 interactome. Diabetologia 48 (2005) 2576-2581
6. Ireland L.M., Yan C.H., Nelson L.M., and Atchison W.D. Differential effects of 2,4-dithiobiuret on the synthesis and release of acetylcholine and dopamine from rat pheochromocytoma (PC12) cells. J. Pharmacol. Exp. Ther. 275 (1995) 1453-1462
7. Kawakami T., Saeki K., Takeyama N., Wu G., Sakudo A., Matsumoto Y., Hayashi T., and Onodera T. Detection of proteolytic cleavages of diabetes-associated protein IA-2 beta in the pancreas and the brain using novel anti-IA-2 beta monoclonal antibodies. Int. J. Mol. Med. 20 (2007) 177-185
8. Knoch K.P., Bergert H., Borgonovo B., Saeger H.D., Altkruger A., Verkade P., and Solimena M. Polypyrimidine tract-binding protein promotes insulin secretory granule biogenesis. Nat. Cell Biol. 6 (2004) 207-214
9. Kubosaki A., Gross S., Miura J., Saeki K., Zhu M., Nakamura S., Hendriks W., and Notkins A.L. Targeted disruption of the IA-2beta gene causes glucose intolerance and impairs insulin secretion but does not prevent the development of diabetes in NOD mice. Diabetes 53 (2004) 1684-1691
10. Kubosaki A., Nakamura S., and Notkins A.L. Dense core vesicle proteins IA-2 and IA-2beta: metabolic alterations in double knockout mice. Diabetes 54 Suppl. 2 (2005) S46-51
11. Lan M.S., Lu J., Goto Y., and Notkins A.L. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol. 13 (1994) 505-514
12. Lan M.S., Wasserfall C., Maclaren N.K., and Notkins A.L. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 6367-6370
13. Lu J., Li Q., Xie H., Chen Z.J., Borovitskaya A.E., Maclaren N.K., Notkins A.L., and Lan M.S. Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 2307-2311
14. Magistrelli G., Toma S., and Isacchi A. Substitution of two variant residues in the protein tyrosine phosphatase-like PTP35/IA-2 sequence reconstitutes catalytic activity. Biochem. Biophys. Res. Commun. 227 (1996) 581-588
15. Mziaut H., Kersting S., Knoch K.P., Fan W.H., Trajkovski M., Erdmann K., Bergert H., Ehehalt F., Saeger H.D., and Solimena M. ICA512 signaling enhances pancreatic beta-cell proliferation by regulating cyclins D through STATs. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 674-679
16. Nishimura T., Kubosaki A., Ito Y., and Notkins A.L. Disturbances in the secretion of neurotransmitters in IA-2/IA-2β null mice: changes in behavior, learning and lifespan. Neuroscience 159 (2009) 427-437
17. Notkins A.L. New predictors of disease. Molecules called predictive autoantibodies appear in the blood years before people show symptoms of various disorders. Tests that detected these molecules could warn of the need to take preventive action. Sci. Am. 296 (2007) 72-79
18. Notkins A.L., and Lernmark A. Autoimmune type 1 diabetes: resolved and unresolved issues. J. Clin. Invest. 108 (2001) 1247-1252
19. Roberts C., Roberts G.A., Lobner K., Bearzatto M., Clark A., Bonifacio E., and Christie M.R. Expression of the protein tyrosine phosphatase-like protein IA-2 during pancreatic islet development. J. Histochem. Cytochem. 49 (2001) 767-776
20. Saeki K., Xie J., and Notkins A.L. Genomic structure of mouse IA-2: comparison with its human homologue. Diabetologia 43 (2000) 1429-1434
21. Saeki K., Zhu M., Kubosaki A., Xie J., Lan M.S., and Notkins A.L. Targeted disruption of the protein tyrosine phosphatase-like molecule IA-2 results in alterations in glucose tolerance tests and insulin secretion. Diabetes 51 (2002) 1842-1850
22. Shoji-Kasai Y., Itakura M., Kataoka M., Yamamori S., and Takahashi M. Protein kinase C-mediated translocation of secretory vesicles to plasma membrane and enhancement of neurotransmitter release from PC12 cells. Eur. J. Neurosci. 15 (2002) 1390-1394
23. Solimena M., Dirkx Jr. R., Hermel J.M., Pleasic-Williams S., Shapiro J.A., Caron L., and Rabin D.U. ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J. 15 (1996) 2102-2114
24. Takeyama N., Ano Y., Wu G., Kubota N., Saeki K., Sakudo A., Momotani E., Sugiura K., Yukawa M., and Onodera T. Localization of insulinoma associated protein 2, IA-2 in mouse neuroendocrine tissues using two novel monoclonal antibodies. Life Sci. (2009)
25. Trajkovski M., Mziaut H., Schubert S., Kalaidzidis Y., Altkruger A., and Solimena M. Regulation of insulin granule turnover in pancreatic {beta}-cells by cleaved ICA512. J. Biol. Chem. 283 (2008) 33719-33729
26. Wasmeier C., and Hutton J.C. Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes. J. Biol. Chem. 271 (1996) 18161-18170
27. Xie H., Deng Y.J., Notkins A.L., and Lan M.S. Expression, characterization, processing and immunogenicity of an insulin-dependent diabetes mellitus autoantigen, IA-2, in Sf-9 cells. Clin. Exp. Immunol. 113 (1998) 367-372